Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos

[MRTX] Mirati Therapeutics Inc Balance Sheet

Data updated 2023-Sep-23 (Saturday)

  Note: Easy to read Balance Sheet for Mirati Therapeutics Inc [NASDAQ:MRTX] with charts that analyze trends of statement items & metrics and compare them with peers

Share       
Others:  
View Financial Statements & visualize data for other stocks
Choose statement type

Choose statement frequency

Annual Balance Sheet values for Mirati Therapeutics Inc are rounded to enhance readability. Hover on cells below for additional contextual info. Key metrics are also provided for your convenience
   2022-Dec  2021-Dec  2020-Dec  2019-Dec  2018-Dec  2017-Dec
   Cash & Short-Term Investments  Detail 1.08 B 1.49 B 1.49 B 1.39 B 415 M 223 M
   Net Receivables  Detail 4 M 3 M 3 M 2 M 2 M 1 M
   Inventory  Detail 3 M -2.51 M -2.3 M -1.57 M -768 K -237 K
   Other Current Assets  Detail 18 M 16.5 M 16.3 M 13.6 M 7.77 M 3.24 M
   Total Current Assets  Detail 1.11 B 1.51 B 1.51 B 1.4 B 424 M 227 M
      Cash Equivalents / Assets  Detail 90.1% 93.8% 93.8% 94.2% 96.1% 97.8%
      Inventory on Hand  Detail 25.2 -249 -397 -42.3 19.1 -5.82
   Long-Term Investments  Detail 4 M 9 M 9 M 17 M 5 M 1 M
   Fixed Assets  Detail 54 M 54 M 54 M 48 M 2 M 525 K
   Other Non-Current Assets  Detail 36 M 18 M 18 M 7 M 1 M -525 K
   Total Non-Current Assets  Detail 94 M 81 M 81 M 72 M 8 M 1 M
   Total Assets  Detail 1.2 B 1.59 B 1.59 B 1.48 B 432 M 228 M
      Return on Assets  Detail -53.1% -46.6% -38.0% -37.5% -64.6% -51.1%
      Asset Turnover  Detail 0.01 0.01 0.05 0.01 0.01 0.07
      Fixed Asset Turnover  Detail 0.23 0.23 1.41 0.54 2.64 17
      Inventory Turnover  Detail 14.5 -1.47 -0.92 -8.62 19.1 -62.7
 
   Accounts Payable  Detail 39 M 35 M 35 M 18 M 16 M 9 M
   Short-Term Debt  Detail 8 M - 5.62 K -48.1 M 1 M -
   Other Current Liabilities  Detail 112 M 109 M 109 M 101 M 32 M 17 M
   Total Current Liabilities  Detail 159 M 144 M 144 M 71 M 49 M 26 M
      Cash Ratio  Detail 681.8% 1,035.4% 1,035.4% 1,957.8% 846.9% 857.7%
      Quick Ratio  Detail 684.3% 1,037.5% 1,037.5% 1,960.6% 851.0% 861.5%
      Current Ratio  Detail 697.5% 1,047.2% 1,047.2% 1,977.5% 865.3% 873.1%
   Long-Term Debt  Detail 44 M 46 M 46 M 42 M - -
   Other Non-Current Liabilities  Detail 3 M 2 M 2 M 2 M 1 M 1 M
   Total Non-Current Liabilities  Detail 47 M 48 M 48 M 44 M 1 M 1 M
   Total Liabilities  Detail 206 M 192 M 192 M 115 M 50 M 27 M
      Debt / Asset  Detail 17.1% 12.1% 12.1% 7.8% 11.6% 11.8%
      Debt / Equity  Detail 20.7% 13.7% 13.7% 8.5% 13.1% 13.4%
      Debt / Capital  Detail 17.1% 12.1% 12.1% 7.8% 11.6% 11.8%
 
   Common Stock  Detail - - 50 K - - -
   Retained Earnings  Detail -2.45 B -1.71 B -1.71 B -1.13 B -772 M -559 M
   Other Equity  Detail 3.45 B 3.11 B 3.11 B 2.49 B 1.15 B 761 M
   Total Shareholder Equity  Detail 997 M 1.4 B 1.4 B 1.36 B 382 M 202 M
      Shareholder Equity / Assets  Detail 82.9% 87.9% 87.9% 92.2% 88.4% 88.6%
      Return on Equity  Detail -61.9% -53.0% -42.2% -41.1% -73.0% -57.1%
   Accumulated Minority Interest  Detail - - - - - -1 M
   Total Equity  Detail 997 M 1.4 B 1.4 B 1.36 B 382 M 201 M

Chart shows absolute values of Cash & Short-Term Investments using annual statements for Mirati Therapeutics Inc. Fiscal Dates standardized to enable peer comparisons


     

 
Select Balance Sheet line/metric for chart. Other fields & statement line items available when different statement type selected
Subsequent stock performance post annual earnings date till next announcement for Mirati Therapeutics Inc. Dates correspond to earnings announcement dates for the period when new financial data became available to the market



Related to Mirati Therapeutics Inc

Information for Mirati Therapeutics Inc

  Current Detail : Recent daily/monthly performance & benchmark comparison
  Historical Detail : Historical performance & related information using Time Machine
  Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
  Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
  Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
  Historical Seasonality : Seasonal performance by calendar months
  Technical History : Popular Technical indicator trends (RSI, MACD etc.)
  Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
  Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
  Moving Averages : Key Simple & Exponential Moving Averages
  Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
  Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
  News Stories : News stories on 2024-Jan-22 on Google
  SEC Reports : Quarterly reports around 2024-Jan-22 on SEC Edgar

Compare Mirati Therapeutics Inc with other assets

  Market Performance : Recent performance across covered assets
  Historical Performance : Prior & Subsequent performance across assets on a historical date
  Market Technicals : Technical indicator levels across covered assets
  Market Seasonality : Seasonal performance by calendar months across covered assets
  Pair Correlations : Performance Correlations with other assets
  Beta : Volatility relative to the broad market
  Performance Comparison : Visually compare/benchmark performance with other assets over time
  Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
  Sector : Health Care sector performance which includes Mirati Therapeutics Inc
  Industry : Biotechnology industry performance which includes Mirati Therapeutics Inc